(RTTNews) - Nxera Pharma Co., Ltd. (4565.T), a technology-powered biopharmaceutical company, on Wednesday announced an exclusive licensing, supply and commercialization agreement with Synmosa Biopharma Corp. (4114.TWO).
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.